Clinical Roundup Analysis of radiotherapy and locoregional recurrence in RxPONDER patients October 28, 2022Vol.48 No.39
In Brief MD Anderson and WHO establish international collaboration to reduce women’s cancers October 21, 2022Vol.48 No.38
Clinical Roundup Individuals with inflammatory breast cancer at higher risk of cancer spread to the brain October 14, 2022Vol.48 No.37
In Brief Michele Coté named director of healthy tissue breast bank at IU Simon September 16, 2022Vol.48 No.33
Clinical Roundup Novartis’ Kisqali provides additional year of survival benefit, including for aggressive HR+/HER2- advanced breast cancer September 16, 2022Vol.48 No.33
Clinical Roundup Study shows specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life September 16, 2022Vol.48 No.33
Drugs & Targets FDA issues safety alert for squamous cell carcinoma and various lymphomas in scar tissue around breast implants September 16, 2022Vol.48 No.33
Clinical Roundup Researchers identify markers of chemotherapy resistance and outcome in TNBC September 09, 2022Vol.48 No.32
Drugs & Targets FDA approves first targeted therapy for HER2-low breast cancer September 09, 2022Vol.48 No.32
Drugs & TargetsFree Lynparza approved by the EC as adjuvant treatment for high-risk breast cancer August 05, 2022Vol.48 No.31
